Back to trainings

MDMA-Assisted Therapy Equivalency Exam

This equivalency exam allows you to fast track to Practical Applications by demonstrating your skills and knowledge from prior training and experience in psychedelic-assisted therapy.

Register Now

About this program

  • Occasions
  • Place
  • Language
  • Price
    399 CAD + tax


Course description

If you have received extensive prior training in psychedelic-assisted therapy (i.e MAPS) and have received approval from the Numinus Training department, you will be eligible to register for this equivalency exam. Please note that this equivalency exam is reserved for highly skilled practitioners and will test various competencies to ensure you meet the necessary skills required to be successful in our Practical Applications course.



In order to register for this exam, you must have:

  • Extensive prior training in psychedelic-assisted therapy (i.e MAPS training)

If you do not meet these prerequisites, please reach out to for recommendations to support you. If you are looking to start your certification journey for psychedelic-assisted therapy with Numinus, please visit Numinus Training’s home page to learn about our certification pathway.


Exam Overview

Please use the arrows below to learn more about how the exam will be structured.

In this module, you will review key concepts and competencies that were introduced in Introduction to Psychedelics, Fundamentals of Psychedelic-Assisted Therapy, Applied Psychedelic-Assisted Therapy, and Molecular Foundations. You will also learn about some approaches and orientations which are unique to Numinus Training programs, like the Numinus Care Model and the Therapeutic Stance.

In part 1 of the exam, you will complete a written exam which consists of 50 multiple choice questions that test your knowledge and application of skills and concepts from Introduction to Psychedelics, Fundamentals of Psychedelic-Assisted Therapy, Applied Psychedelic-Assisted Therapy, and Molecular Foundations. There will also be 3 case questions where you can demonstrate your ability to apply what you've learned in your prior training. 

In part 2 of the exam, you will complete a written or video-recorded reflection where you will demonstrate that you possess the necessary competencies and orientations for health professionals working with psychedelic-assisted therapy, as outlined in the Numinus Therapeutic Stance and the Numinus Care Model.

Learning Outcomes

After successfully completing this exam, you will have demonstrated that you are able to:

  • Categorize psychedelics according to their shared properties, effects, and primary mechanism of action.

  • Compare the outcomes of psychedelic-assisted therapy and traditional psychopharmacological therapy.

  • Outline key historical events that have contributed to the development of psychedelic-assisted therapy.

  • List key studies that have investigated the outcomes of psychedelic-assisted therapy.

  • Describe the potential for risk of using psychedelic medicines inside and outside of a clinical setting.

  • Describe the unique vulnerabilities of clients participating in psychedelic-assisted therapy and cultivate the awareness and practices necessary to meet these vulnerabilities safely and ethically.

  • Apply and demonstrate relevant facilitation competencies, skills, and orientations (including the Numinus care model) at an introductory level for the purposes of delivering psychedelic-assisted therapy.

  • Describe the Numinus guiding principles within the context of integrative and transformative mental wellness as they relate to psychedelic-assisted therapy.

  • Apply facilitation skills specific to psychedelic-assisted therapy during Preparation Sessions, Medicine Sessions, and Integration Sessions.

  • Identify and respond to burnout, vicarious trauma, transference, and countertransference experienced by the health professional.

  • Determine the symptoms and appropriate treatments for the conditions presented.

  • Integrate different perspectives regarding assessment and treatment approaches applied to psychedelic-assisted therapy.

  • Discuss key psychedelic-assisted therapy research and proposed therapeutic mechanisms.

  • Apply best practices for preparation, medicine, and integration sessions.

  • Assess client’s suitability for treatment according to relative and absolute contraindications.

  • Identify potential challenges and risks associated with these disorders and limitations of psychedelic-assisted therapy as a brief intervention.

  • Apply pharmacological knowledge of MDMA to the facilitation or development of a psychedelic-assisted therapy protocol in a clinical setting.

  • Compare the wide range of effects, side effects, effects of long-term use, and abuse potential of MDMA.

  • Apply cultural safety and humility to the administration of MDMA as part of psilocybin-assisted therapy in order to avoid cultural appropriation and cultural harm.

  • Screen clients and determine if MDMA would be best suited for a given client or clinical presentation.


The continuing professional development program in no way promotes, condones, or facilitates illegal activity, and is strictly for educational and harm reduction purposes only. Please be aware that certain psychedelic substances still remain illegal in many jurisdictions, including Canada. This program and the contents of this website do not constitute medical advice, and are not a substitute for professional medical advice and treatment.


After successfully completing the exam, you will receive a certificate of completion, however this certificate cannot be claimed for continuing education credit with your licensing body.

Yes, just be mindful of the time zones! Please also note that daylight saving time in North America typically comes into effect on different dates than some other parts of the world.

Please also note that while this exam can be completed from anywhere, the subsequent Practical Applications course is in person.

Please consult the Numinus Practictioner Training Policies for more information about our policies.

No, this exam and the review content are not eligible for continuing education credit.

We’re happy to help. Send us an e-mail at

In order to pass the exam, you need to achieve 80% or higher. If you achieve 70-79%, you will be eligible to rewrite the exam once to achieve 80% or higher. If you achieve less than 70%, you will need to take the full certification pathway.

We want to connect with you!

Sign up here so we can keep in touch.